News

Danish pharmaceutical company Novo Nordisk and biotechnology developer Orbis Medicines have entered into a drug discovery and licensing agreement valued at up to $1.4 billion to develop oral therapies for cardiometabolic diseases. The program aims to advance oral alternatives...

Generating a molecule is easy for a modern AI model. Generating one that a discovery team should actually make is considerably harder. A useful candidate has to satisfy several constraints at once. It may need stronger binding without losing...

Senior officials at the US Food and Drug Administration have signaled that the agency is open to novel and innovative approaches in the clinical development of psychedelic drugs, citing the worsening mental health crisis across the United States. The...

ABEC is set to open a new manufacturing facility in Wilson, North Carolina, further strengthening its network of biopharmaceutical process equipment and consumables production. A ribbon-cutting ceremony to mark the occasion is scheduled for 24 September, with company leadership,...

The National Commission into the Regulation of AI in Healthcare has delivered its long-awaited report, setting out a framework for deploying artificial intelligence tools within the National Health Service in a manner described as "safe, fast, and trusted." Commissioned by...

Jiangsu Hengrui Pharma has secured a landmark regulatory clearance in China for its oral thrombopoietin (TPO) receptor agonist hetrombopag, making it the first oral TPO agonist anywhere in the world to receive approval for chemotherapy-induced thrombocytopenia (CIT). The approval...

Introduction For e-commerce platforms, hospital procurement directors, healthcare supply chain managers, and medical device importers, hearing aid sourcing has moved far beyond simple price-per-unit comparisons. The international medical device landscape now demands verifiable regulatory compliance, robust factory documentation, and data...